Back to top

Image: Bigstock

Teradyne (TER) Beats Earnings and Revenue Estimates in Q4

Read MoreHide Full Article

Teradyne Inc. (TER - Free Report) reported fourth-quarter 2017 earnings of 46 cents per share, surpassing the Zacks Consensus Estimate by 12 cents. Earnings decreased 15% sequentially but increased 44% year over year.

Given the popularity of its products, acquisition of Universal Robots and continuous design wins, we are optimistic about Teradyne’s performance in the long run. However, weakness in the wireless Test market could be a near-term concern.

On a 12-month basis, the stock has outperformed the industry it belongs to. It has returned 71.8% compared with the industry’s gain of 51.7%.

Revenues

Revenues of $479.4 million decreased 4.8% sequentially but increased 26.2% year over year. Also, the figure came in above the Zacks Consensus Estimate of $437.9 million and above management’s guided range of $420-$450 million.

Approximately 66% of the revenues came from semiconductor Testing platforms, 11% from Industrial Automation, 17% from system Test business and the remaining 6% from wireless Test business.

Booking

Total orders amounted to $560 million, increasing 36.6% sequentially but decreasing 10.8% from the year-ago quarter.

On a sequential basis, only Wireless Test orders were down 27.3% to $24 million, while all others increased. Systems Test orders were up 64.3% year over year, Semiconductor Test orders increased 39%, while Industrial Automation orders were up 40%.

Margins

According to the press release, pro forma gross margin was 56.5%, down 210 basis points (bps) sequentially and 90 bps year over year. The decrease was due to unfavorable mix.

Total adjusted operating expenses of $158.6 million increased 8.4% year over year. As a percentage of sales, both engineering & development expenses and selling & administrative expenses decreased. As a result, adjusted operating margin came in at 23.1%, down 300 bps sequentially but up 450 bps year over year.

GAAP net loss was $105.9 million in the fourth quarter against net income of $66.3 million in the year-ago quarter. Excluding special items but including stock-based compensation expense, non-GAAP net income came in at $91.4 million or 46 cents per share compared with $64.6 million or 32 cents in the year-ago quarter.

Balance Sheet

Teradyne ended the quarter with cash and cash equivalents and marketable securities balance of $1.78 billion, up from $1.64 billion in the prior quarter. Trade receivables were $272.8 million, up from $268.1 million last quarter.

Cash flow from operations was $147.5 million compared with $309.8 million in the previous quarter. Capex was $32.1 million compared with $27.3 million in the third quarter.

Share Repurchase/Dividend

In the reported quarter, Teradyne spent $48.5 million on share repurchases and paid $13.7 million as dividend.

During the quarter, the company approved a new share repurchase program up to $1.5 billion through open market purchases or private transactions.  The $1.5 billion authorization replaces the company’s existing $500 million repurchase authorization announced in December 2016.

Q1 Guidance

Management expects first-quarter revenues in the range of $460-$490 million, decreasing 1% sequentially at the mid-point. The Zacks Consensus Estimate is pegged at $483.0 million.

Non-GAAP earnings per share from continuing operations are likely to be in the range of 38-45 cents. The Zacks Consensus Estimate is pegged at 43 cents. GAAP earnings are expected in the range of 32-39 cents.

Teradyne, Inc. Price, Consensus and EPS Surprise

 

Teradyne, Inc. Price, Consensus and EPS Surprise | Teradyne, Inc. Quote

Other Stocks to Consider

Currently, Teradyne carries a Zacks Rank#3 (Hold). A few better-ranked stocks in the broader technology sector are PetMed Express (PETS - Free Report) , sporting a Zacks Rank #1 (Strong Buy), while ASML Holding N.V. (ASML - Free Report) and Lam Research Corporation (LRCX - Free Report) , sporting a Zacks Rank #2 (Buy) each. You can see the complete list of today’s Zacks #1 Rank stocks here.

Long-term earnings per share growth rate for PetMed Express, ASML Holding and Lam Research is projected to be 10%, 18.7% and 14.9%, respectively.

Today's Stocks from Zacks' Hottest Strategies

It's hard to believe, even for us at Zacks. But while the market gained +18.8% from 2016 - Q1 2017, our top stock-picking screens have returned +157.0%, +128.0%, +97.8%, +94.7%, and +90.2% respectively.

And this outperformance has not just been a recent phenomenon. Over the years it has been remarkably consistent. From 2000 - Q1 2017, the composite yearly average gain for these strategies has beaten the market more than 11X over. Maybe even more remarkable is the fact that we're willing to share their latest stocks with you without cost or obligation.

See Them Free>>

Published in